AACR-NCI-EORTC

Augurex Life Sciences Granted FDA Breakthrough Designation for SPINEstat

Vancouver, Canada, Oct. 28, 2025 — Augurex Life Sciences announced FDA Breakthrough Device Designation for its SPINEstat® blood test,...

By cGxPwire Editor
October 28, 2025

Bio-Pharma

OncoNano Showcases Novel Cancer Therapeutics at AACR-NCI-EORTC 2025

Dallas, TX – October 24, 2025: OncoNano Medicine, a clinical-stage biotechnology company, announced it will present new data at...

By cGxPwire Editor
October 27, 2025

Bio-Pharma

Whitehawk Therapeutics Identifies PTK7 as a Broadly Expressed ADC Target Across Solid Tumors

MORRISTOWN, N.J. | October 24, 2025 — Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology-focused biopharmaceutical company pioneering next-generation antibody-drug...

By cGxPwire Editor
October 24, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Augurex Life Sciences Granted FDA Breakthrough Designation for SPINEstat

OncoNano Showcases Novel Cancer Therapeutics at AACR-NCI-EORTC 2025

Whitehawk Therapeutics Identifies PTK7 as a Broadly Expressed ADC Target Across Solid Tumors